GB202215141D0 - Novel cell line and its use in therapy - Google Patents

Novel cell line and its use in therapy

Info

Publication number
GB202215141D0
GB202215141D0 GBGB2215141.9A GB202215141A GB202215141D0 GB 202215141 D0 GB202215141 D0 GB 202215141D0 GB 202215141 A GB202215141 A GB 202215141A GB 202215141 D0 GB202215141 D0 GB 202215141D0
Authority
GB
United Kingdom
Prior art keywords
therapy
cell line
novel cell
novel
line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2215141.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of York
Original Assignee
University of York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of York filed Critical University of York
Priority to GBGB2215141.9A priority Critical patent/GB202215141D0/en
Publication of GB202215141D0 publication Critical patent/GB202215141D0/en
Priority to PCT/GB2023/052662 priority patent/WO2024079480A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
GBGB2215141.9A 2022-10-13 2022-10-13 Novel cell line and its use in therapy Pending GB202215141D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2215141.9A GB202215141D0 (en) 2022-10-13 2022-10-13 Novel cell line and its use in therapy
PCT/GB2023/052662 WO2024079480A1 (en) 2022-10-13 2023-10-13 Novel cell line and its use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2215141.9A GB202215141D0 (en) 2022-10-13 2022-10-13 Novel cell line and its use in therapy

Publications (1)

Publication Number Publication Date
GB202215141D0 true GB202215141D0 (en) 2022-11-30

Family

ID=84818417

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2215141.9A Pending GB202215141D0 (en) 2022-10-13 2022-10-13 Novel cell line and its use in therapy

Country Status (2)

Country Link
GB (1) GB202215141D0 (en)
WO (1) WO2024079480A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101640381B1 (en) * 2008-02-22 2016-07-18 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Mesenchymal stem cell particles
WO2021198927A1 (en) * 2020-03-30 2021-10-07 Universidade Do Minho Compositions for therapy or treatment of parkinson's disease, methods and uses thereof

Also Published As

Publication number Publication date
WO2024079480A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
IL291579A (en) Cbl inhibitors and compositions for use in adoptive cell therapy
ZA200703699B (en) Nitrobenzindoles and their use in cancer therapy
EP4092798A4 (en) Gel electrolyte precursor and use thereof
IL308147A (en) Production bacterial cells and use thereof in production methods
GB202215141D0 (en) Novel cell line and its use in therapy
GB202215142D0 (en) Novel cell lines and their use in therapy
GB202014736D0 (en) Novel compounds and their use in therapy
GB2600981B (en) Improvements in and relating to positioning
GB202305546D0 (en) Novel compounds and their use in therapy
GB202305541D0 (en) Novel compounds and their use in therapy
GB202114446D0 (en) Improvements in and relating to ProSe
EP4125951A4 (en) Combination therapy involving anti-cd39 antibodies and adoptive cell therapy
GB202403391D0 (en) Novel compounds and their use in therapy
GB202110932D0 (en) Novel compounds and their use in therapy
GB202011808D0 (en) Novel compounds and their use in therapy
IL304496A (en) T cells for use in therapy
IL280555A (en) Substituted benzamides and their use in therapy
IL309249A (en) Conjugates comprising phosphoantigens and their use in therapy
AU2022900994A0 (en) Conjugates and their use in therapy
AU2020903727A0 (en) Conjugates and their use in therapy
GB2581035B (en) Novel compounds and their use in therapy
GB202316080D0 (en) Improvements in or relating to devices and methods
GB202319999D0 (en) Improvements in and relating to construction
GB202211217D0 (en) Improvements in and relating to cell configuration and control
GB202303254D0 (en) Improvements in and relating to heater devices